Issue 7, 2012

New 3-amidinophenylalanine-derived inhibitors of matriptase

Abstract

New 3-amidinophenylalanine-derived matriptase inhibitors were developed and tested against the related trypsin-like serine proteases matriptase-2, thrombin and factor Xa. The strongest matriptase inhibition was found for compounds containing an N-terminal 2′,4′-dichloro- or 2′,4′-dimethoxy-biphenyl-3-sulfonyl group. The combination with a C-terminal piperidyl-cyclohexylurea residue provided the first monobasic matriptase inhibitor with a Ki value < 3 nM and excellent selectivity over thrombin. The X-ray structure of a representative analogue in complex with thrombin superimposed with matriptase provides information regarding the selectivity profile observed in this study.

Graphical abstract: New 3-amidinophenylalanine-derived inhibitors of matriptase

Supplementary files

Article information

Article type
Concise Article
Submitted
20 Mar 2012
Accepted
06 May 2012
First published
08 May 2012

Med. Chem. Commun., 2012,3, 807-813

New 3-amidinophenylalanine-derived inhibitors of matriptase

M. Hammami, E. Rühmann, E. Maurer, A. Heine, M. Gütschow, G. Klebe and T. Steinmetzer, Med. Chem. Commun., 2012, 3, 807 DOI: 10.1039/C2MD20074K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements